Evaluasi Penggunaan Obat Antituberculosis pada Pasien Tuberculosis Paru di Puskesmas Bumijawa Tahun 2023

Penulis

  • Nur Naily Nisya Program Studi Farmasi, Fakultas Sains dan Teknologi, Universitas Peradaban, Jalan Raya KM 3 Paguyangan, Paguyangan Brebes, Jawa Tengah 52276, Indonesia
  • Aziez Ismunandar Program Studi Farmasi, Fakultas Sains dan Teknologi, Universitas Peradaban, Jalan Raya KM 3 Paguyangan, Paguyangan Brebes, Jawa Tengah 52276, Indonesia
  • Baedi Mulyanto Program Studi Farmasi, Fakultas Sains dan Teknologi, Universitas Peradaban, Jalan Raya KM 3 Paguyangan, Paguyangan Brebes, Jawa Tengah 52276, Indonesia

Abstrak

Tuberculosis is an infectious disease caused by Mycrobacteria and is contagious. M. tuberculosis is spread from person to person through coughing or sneezing. Direct contact with people with tuberculosis is likely to contract the infection. The purpose of the study was to determine the percentage of drug selection accuracy, indication accuracy and dose accuracy in the use of OAT for tuberculosis patients and to determine the pattern of antituberculosis drug use in tuberculosis patients at the outpatient installation of the Bumijawa Health Center in 2023. The technique used by researchers is purposive sampling technique. This technique is used to capture as much information or data as possible. The purposive sampling technique required considerations to select and determine the data to be sampled. Researchers must choose samples that are considered to know the problems that occur as well as what is expected in the study. Data analysis for this research is descriptive analysis. All data collected during the study will be grouped based on the type of drug, dose of how to use and frequency of administering drugs, as well as calculating the percentage of accuracy in prescribing drugs, correct use, correct dosage, and reasonableness of all therapy . Then analyzed using univariate analysis. Based on the results of research evaluating the use of anti-tuberculosis drugs in pulmonary tuberculosis patients at Bumijawa Medical Center, the population was 110 people and the number of samples that met the inclusion criteria was 46 patients. This research concludes that overall the Bumijawa Community Health Center has met the national standards for tuberculosis control issued by the Ministry of Health of the Republic of Indonesia in 2014, from the identification of tuberculosis diagnosis and control services to the selection of treatment guidelines. Tuberculosis treatment at the Bumijawa Community Health Center shows 100% accuracy in drug selection, 100% accuracy in prescriptions, 100% accuracy in dosage and 100% accuracy in drug administration which is 93.5%. The pattern of use of anti-tuberculosis drugs in outpatients at the Bumijawa Community Health Center follows the national guidelines for controlling tuberculosis issued by the Indonesian Ministry of Health in 2014.

Diterbitkan

2024-07-10

Cara Mengutip

Nisya, N. N., Ismunandar, A., & Mulyanto, B. (2024). Evaluasi Penggunaan Obat Antituberculosis pada Pasien Tuberculosis Paru di Puskesmas Bumijawa Tahun 2023. Jurnal Farmasi Universitas Peradaban, 4(2), 219–227. Diambil dari https://journal.peradaban.ac.id/index.php/ppj/article/view/1918

Artikel paling banyak dibaca berdasarkan penulis yang sama

1 2 > >>